Paper · 18171981
Complete suppression of tumor formation by high levels of basement membrane collagen.
Harris A and 2 others. Mol Cancer Res, 2007. Cited by 27 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Complete suppression of tumor formation by high levels of basement membrane collagen. Papers, record 18171981. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18171981
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Basement Membrane | Major topic |
| Collagen | Major topic |
| Fibroblasts | Major topic |
| Uterine Cervical Neoplasms | Major topic |
| Animals | |
| Female | |
| Gene Expression Regulation, Neoplastic | |
| HeLa Cells | |
| Humans | |
| Mice | |
| Mice, Nude | |
| Neoplasm Transplantation | |
| Transfection |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U01 CA111294 | NCI NIH HHS | United States | U01CA111294 | PubMed and NIH | NIH RePORTER |
| R21 CA129258 | NCI NIH HHS | United States | R21CA129258 | PubMed and NIH | NIH RePORTER |
| CA129258 | NCI NIH HHS | United States | R21CA129258 | PubMed and NIH | NIH RePORTER |
| P30 CA036727 | NCI NIH HHS | United States | P30CA036727 | PubMed and NIH | NIH RePORTER |
| U01CA111294 | NCI NIH HHS | United States | U01CA111294 | PubMed and NIH | NIH RePORTER |
| CA36727 | NCI NIH HHS | United States | P30CA036727 | PubMed and NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17,331,945 | Collagen XXVII is developmentally regulated and forms thin fibrillar structures distinct from those of classical vertebrate fibrillar collagens. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17331945 | PubMed |
| 2 | 10,791,950 | Basement membrane zone type XV collagen is a disulfide-bonded chondroitin sulfate proteoglycan in human tissues and cultured cells. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10791950 | PubMed |
| 3 | 15,906,535 | Immunohistochemical studies comparing the localization of type XV collagen in normal human skin and skin tumors with that of type IV collagen. | J Dermatol | 2005 | https://conductscience.org/library/papers/15906535 | PubMed |
| 4 | 15,698,950 | Identification and characterization of novel endogenous proteolytic forms of the human angiogenesis inhibitors restin and endostatin. | Biochim Biophys Acta | 2005 | https://conductscience.org/library/papers/15698950 | PubMed |
| 5 | 15,684,329 | Proteoglycan-collagen XV in human tissues is seen linking banded collagen fibers subjacent to the basement membrane. | J Histochem Cytochem | 2005 | https://conductscience.org/library/papers/15684329 | PubMed |
| 6 | 10,049,780 | Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. | Biochem Biophys Res Commun | 1999 | https://conductscience.org/library/papers/10049780 | PubMed |
| 7 | 9,176,399 | Location of type XV collagen in human tissues and its accumulation in the interstitial matrix of the fibrotic kidney. | Am J Pathol | 1997 | https://conductscience.org/library/papers/9176399 | PubMed |
| 8 | 8,929,352 | Type XV collagen exhibits a widespread distribution in human tissues but a distinct localization in basement membrane zones. | Cell Tissue Res | 1996 | https://conductscience.org/library/papers/8929352 | PubMed |
| 9 | 2,448,320 | The suppression of malignancy by terminal differentiation: evidence from hybrids between tumour cells and keratinocytes. | J Cell Sci | 1987 | https://conductscience.org/library/papers/2448320 | PubMed |
| 10 | 3,833,868 | Suppression of malignancy in hybrid cells: the mechanism. | J Cell Sci | 1985 | https://conductscience.org/library/papers/3833868 | PubMed |
1 to 10 of 18
See all 18 referencesCited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,088,036 | Pan-cancer analysis of COL15A1: an immunological and prognostic biomarker. | Discov Oncol | 2024 | https://conductscience.org/library/papers/39088036 | PubMed |
| 38,371,376 | Fine-scale mapping of chromosome 9q22.33 identifies candidate causal variant in ovarian cancer. | PeerJ | 2024 | https://conductscience.org/library/papers/38371376 | PubMed |
| 36,388,672 | Collagen XV mediated the epithelial-mesenchymal transition to inhibit hepatocellular carcinoma metastasis. | J Gastrointest Oncol | 2022 | https://conductscience.org/library/papers/36388672 | PubMed |
| 34,853,731 | Clusterin suppresses invasion and metastasis of testicular seminoma by upregulating COL15a1. | Mol Ther Nucleic Acids | 2021 | https://conductscience.org/library/papers/34853731 | PubMed |
| 34,576,139 | Deletion of Col15a1 Modulates the Tumour Extracellular Matrix and Leads to Increased Tumour Growth in the MMTV-PyMT Mouse Mammary Carcinoma Model. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34576139 | PubMed |
| 28,283,548 | Smooth muscle cell-specific deletion of Col15a1 unexpectedly leads to impaired development of advanced atherosclerotic lesions. | Am J Physiol Heart Circ Physiol | 2017 | https://conductscience.org/library/papers/28283548 | PubMed |
| 27,390,605 | Increased Expression of Several Collagen Genes is Associated with Drug Resistance in Ovarian Cancer Cell Lines. | J Cancer | 2016 | https://conductscience.org/library/papers/27390605 | PubMed |
| 26,277,786 | Expression profiling of angiogenesis-related genes in brain metastases of lung cancer and melanoma. | Tumour Biol | 2016 | https://conductscience.org/library/papers/26277786 | PubMed |
| 24,043,668 | Collagen XV: exploring its structure and role within the tumor microenvironment. | Mol Cancer Res | 2013 | https://conductscience.org/library/papers/24043668 | PubMed |
| 23,991,074 | Collagen XV inhibits epithelial to mesenchymal transition in pancreatic adenocarcinoma cells. | PLoS One | 2013 | https://conductscience.org/library/papers/23991074 | PubMed |
1 to 10 of 18
See all 18 cited byGenes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| COL15A1 | 1,306 | PubTator's text mining | https://conductscience.org/library/genes/1306 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18171981
GET https://conductscience.org/api/papers/v1/18171981/authors